R&D News | pharmaphorum

News

Moderna to raise $1.34bn for late-stage COVID-19 vaccine tri...

Moderna’s COVID-19 vaccine has produced a strong immune response in early trials – but will it be able to prevent infections on a large scale?

News

Canada joins COVID-19 vaccine race after okaying trials of f...

The race is on to find a vaccine for COVID-19 and Canada’s government may have taken the lead after its national drug regulator cleared a plan to begin studying the front-running candidate.

News

Sorrento surges on antibody ‘shield’ trials for coronavirus

Shares in Sorrento Therapeutics rose 158% on Friday after it revealed plans to start human trials of an antibody therapy that achieved complete inhibition of the coronavirus in

News

COVID-19 vaccine row escalates as Macron calls meeting with ...

No-one even knows if it is possible to make a vaccine against COVID-19 and already there is an escalating row about cost and equitable access if one succeeds in clinical trials.

News

Sanofi CEO courts controversy after saying US is first in li...

Sanofi’s CEO Paul Hudson has courted controversy by saying the French pharma’s potential COVID-19 vaccine will likely be delivered to the US government first should it succeed in clinical t

News

UK starts human gene sequencing project to aid COVID-19 figh...

In a landmark study, thousands of NHS patients will have their DNA studied to see how a person’s genetic profile plays a role in susceptibility to COVID-19.

Moderna to raise $1.34bn for late-stage COVID-19 vaccine tri...

Canada joins COVID-19 vaccine race after okaying trials of f...

Sorrento surges on antibody ‘shield’ trials for coronavirus

COVID-19 vaccine row escalates as Macron calls meeting with ...

Sanofi CEO courts controversy after saying US is first in li...

UK starts human gene sequencing project to aid COVID-19 figh...

Lilly inflates US facility investment spending by $4.5bn

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks